Clinical trial
Swallowing Sparing IMRT (SW-IMRT) Versus Standard Parotid Sparing IMRT (ST-IMRT) in the Treatment of Head and Neck Cancer
NCT04597177 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Swallowing Sparing IMRT (SW-IMRT) Versus Standard Parotid Sparing IMRT (ST-IMRT) in the Treatment of Head and Neck Cancer
- Lead sponsor
- National Cancer Institute, Egypt
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 1, 2015
- Completion date
- December 30, 2022
- Enrollment
- 146 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
swallowing dysfunction